metaviatx.com (MTVA) Company Long-Term Loans and Borrowings

Official company branding of MetaVia Inc. (MTVA)

MetaVia Inc (MTVA) prospects rely on the development of tools for aneurysm and stroke therapy, where regulatory approval and physician recognition will be the key success factors. The current stage of development is characterized by early-phase clinical research, and financial stability remains independent of external economic cycles, reaching the level of 0.00. Market share price volatility complements the profile of this R&D-intensive biotech firm, which attracts leading researchers with its development of dementia drugs.

MTVA (MetaVia Inc) Company Long-Term Debt history from 11/30/2024 to 10/28/2026

Metric breakdowns and analytics for MetaVia (MTVA)

- price and consensus price forecast:
Stock Price MetaVia Inc.|MTVA - Price Target Chart
- market capitalization data:
Market Value MetaVia|MTVA - Total Company Value
- book capitalization data:
Net Asset Value per Share MetaVia|MTVA - Company Book Value|Market Cap to Net Assets Ratio metaviatx.com|MTVA - Company Total Assets
- debt and liquidity data:
Debt to Capital MetaVia Inc|MTVA - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio MetaVia Inc.|MTVA - Company Aggregate Debts|Debts to Book Capitalization MetaVia|MTVA - Company Long-Term Liabilities|Company Short-Term Debt MetaVia
Summary company analytics:MTVA - MetaVia Inc
Mass-produced product of metaviatx.com

Developing unique molecules for the therapy of neurodegenerative pathologies requires large-scale investments, which are often covered by long-term financing. By analyzing the size of the business's long-term debt capital, an investor assesses the total liabilities with a maturity of more than one year, which allows for the determination of the financial stability of MetaVia Inc. (MTVA) and the company's ability to sustain the R&D cycle until the commercialization of patents.

Competitors of MetaVia Inc (MTVA)

biogen.com - Company Long-Term Debts|Company Long-Term Debt Neurocrine Biosciences, Inc. (NBIX)|RGC: Company Long-Term Loans and Borrowings|Company Long-Term Debt AXSM|ACAD (ACADIA Corp) - Long-Term Debt|Company Long-Term Debt XENE|Company Long-Term Liabilities vikingtherapeutics.com|Supernus - Company Long-Term Debts|Long-Term Debt Catalyst Pharma CPRX|Company Long-Term Liabilities Denali Therapeutics Inc (DNLI)|Amount of Long-Term Liabilities Harmony Corp HRMY|Biohaven Ltd. - Company Long-Term Debts|amylyx.com (AMLX) - Company Long-Term Debts|Trevi Therapeutics, Inc. (TRVI) - Company Long-Term Liabilities|Praxis Precision Medicines Inc (PRAX) - Company Long-Term Debt|AVXL: Company Long-Term Debts|Long-Term Debt Volume CeriBell EEG|Company Long-Term Debts PRTA|Company Long-Term Debts alector.com ALEC|Company Long-Term Liabilities Annexon|Company Long-Term Loans and Borrowings Omeros Corp OMER|Company Long-Term Debts NGNE (Neurogene Corp)|ACIU: Long-Term Debt Volume|Company Long-Term Debt Voyager Therapeutics|neumoratx.com (NMRA) - Company Long-Term Indebtedness|Company Long-Term Debts SCLX|Company Long-Term Liabilities TVGN|Company Long-Term Debt ACOG (Alpha Cognition)|Company Long-Term Liabilities cogrx.com CGTX|Company Long-Term Liabilities Inhibikase Therapeutics (IKT)|SAVA - Amount of Long-Term Liabilities|ASRT - Company Long-Term Liabilities|COYA - Company Long-Term Debt|VTGN: Company Long-Term Debts|OVID (Ovid Therapeutics) - Company Long-Term Debts|Company Long-Term Debt Acumen Pharmaceuticals (ABOS)|Company Long-Term Indebtedness cervomed.com|Alterity Therapeutics - Company Long-Term Debts|Long-Term Debt clene.com CLNN|Company Long-Term Liabilities PEPG (PepGen)|jupiterneurosciences.com - Company Long-Term Debts|Company Long-Term Debt Relmada Therapeutics (RLMD)|ANVS: Company Long-Term Loans and Borrowings|Company Long-Term Debt GRCE|AIFF (Firefly Neuroscience, Inc.) - Long-Term Debt|Company Long-Term Debt KLTO|Company Long-Term Liabilities NeuroSense Therapeutics, Ltd.|Reviva Pharmaceuticals - Company Long-Term Debts|Long-Term Debt neuraxis.com NRXS|Company Long-Term Liabilities Helius Medical Technologies (HSDT)|Amount of Long-Term Liabilities Passage Bio Inc. PASG|Neuphoria - Company Long-Term Debts|Minerva (NERV) - Company Long-Term Debts|Athira Pharma, Inc. (ATHA) - Company Long-Term Liabilities|addextherapeutics.com (ADXN) - Company Long-Term Debt|ALZN: Company Long-Term Debts|Long-Term Debt Volume Cyclerion|Company Long-Term Debts PTIX|Company Long-Term Debts pasitheaclinics.com KTTA|Company Long-Term Liabilities Cortigent|Company Long-Term Loans and Borrowings avenuetx.com ATXI|Company Long-Term Debts BCLI (BrainStorm Cell Therapeutics)|CARA: Long-Term Debt Volume|Company Long-Term Debt Chromocell Therapeutics Corporation|Eliem Therapeutics Inc. (ELYM) - Company Long-Term Indebtedness|Company Long-Term Debts ITCI|Company Long-Term Liabilities LBPH|Company Long-Term Debt MRNS (Marinus Pharmaceuticals, Inc.)|Company Long-Term Liabilities NKGen Biotech Inc NKGN|Company Long-Term Liabilities NeuroBo (NRBO)|SAGE - Amount of Long-Term Liabilities|SNPX - Company Long-Term Liabilities|TRVN - Company Long-Term Debt|VIGL: Company Long-Term Debts|WENA (Anew Medical Inc.) - Company Long-Term Debts|Company Long-Term Debt Cerevel (CERE)